194 related articles for article (PubMed ID: 8619718)
1. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172.
Wilhelm MJ; Schmid C; Kececioglu D; Möllhoff T; Ostermann H; Scheld HH
Ann Thorac Surg; 1996 Mar; 61(3):920-4. PubMed ID: 8619718
[TBL] [Abstract][Full Text] [Related]
2. Heparin induced thrombocytopenia. Experiences in 12 heart surgery patients.
Sodian R; Loebe M; Gorman KF; Riess H; Hetzer R
ASAIO J; 1997; 43(5):M430-3. PubMed ID: 9360077
[TBL] [Abstract][Full Text] [Related]
3. [Use of Organon, a synthetic heparinoid, in two cardiopulmonary bypass procedures in the same patient sensitive to heparin].
Pineau E; Le Bret E; Folliguet T; Saint Maurice OS; Carbognani D; Laborde F
Arch Mal Coeur Vaiss; 2001 Feb; 94(2):144-7. PubMed ID: 11265553
[TBL] [Abstract][Full Text] [Related]
4. [Extracorporeal circulation with danaparoid sodium for valve replacement in thrombocytopenia induced by type II heparin].
Salmi L; Leroy-Matheron C; LeBesnerais P; Rosanval O; Duvaldestin P; Gouault-Heilmann M
Ann Fr Anesth Reanim; 2001 Nov; 20(9):799-802. PubMed ID: 11759322
[TBL] [Abstract][Full Text] [Related]
5. Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).
Saxon BR; Black MD; Edgell D; Noel D; Leaker MT
Ann Thorac Surg; 1999 Sep; 68(3):1076-8. PubMed ID: 10510017
[TBL] [Abstract][Full Text] [Related]
6. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.
Gillis S; Merin G; Zahger D; Deeb M; Drenger B; Hyam E; Eldor A
Br J Haematol; 1997 Sep; 98(3):657-9. PubMed ID: 9332322
[TBL] [Abstract][Full Text] [Related]
7. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
Olin DA; Urdaneta F; Lobato EB
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
[No Abstract] [Full Text] [Related]
8. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia type II: successful use of Orgaran (ORG 10172) in intensive care patients.
Burkhard-Meier U; Söhngen D; Schultheiss HP; Greinacher A; Schwartzkopff B; Vogt M; Heyll A; Schneider W
Intensive Care Med; 1995 Jun; 21(6):542-3. PubMed ID: 7560499
[No Abstract] [Full Text] [Related]
10. The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations.
Hill GR; Hickton C; Henderson S; Patton WN
Clin Lab Haematol; 1997 Jun; 19(2):155-7. PubMed ID: 9218159
[TBL] [Abstract][Full Text] [Related]
11. [Value of orgaran in hemodialysis during heparin-induced thrombopenia].
Lamriben L; Tiberghien F; Delacour JL; Floriot C; Wagschal G; Daoudal P; Ory JP
Presse Med; 1996 Sep; 25(28):1303. PubMed ID: 8949796
[No Abstract] [Full Text] [Related]
12. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
[No Abstract] [Full Text] [Related]
13. [Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].
Mahul P; Raynaud J; Favre JP; Jospé R; Décousus H; Auboyer C
Ann Fr Anesth Reanim; 1995; 14(1):29-32. PubMed ID: 7677282
[TBL] [Abstract][Full Text] [Related]
14. [Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy].
Tardy-Poncet B; Reynaud J; Tardy B; Mahul P; Mismetti P; Beraud AM; Rebaud MA; Bayon M; Guyotat D
Presse Med; 1996 May 4-11; 25(16):751-5. PubMed ID: 8692750
[TBL] [Abstract][Full Text] [Related]
15. Orgaran (Org 10172) for cardiopulmonary bypass in heparin-induced thrombocytopenia: role of adjunctive plasmapheresis.
Schmahl KS; Ganjoo AK; Harloff MG
J Cardiothorac Vasc Anesth; 1997 Apr; 11(2):262-3. PubMed ID: 9106004
[No Abstract] [Full Text] [Related]
16. Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II.
Zöhrer' B; Zenz W; Rettenbacher A; Covi P; Kurnik K; Kroll H; Grubbauer HM; Muntean W
Acta Paediatr; 2001 Jul; 90(7):765-71. PubMed ID: 11519979
[TBL] [Abstract][Full Text] [Related]
17. Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome.
Tardy/Poncet B; Mahul P; Beraud AM; Favre JP; Tardy B; Guyotat D
Br J Haematol; 1995 Aug; 90(4):969-70. PubMed ID: 7669684
[No Abstract] [Full Text] [Related]
18. [Cardiac surgery in patients with heparin-induced thrombocytopenia (HIT II)].
Jović MD; Nezić DG; Calija BM; Nenadić DS; Knezević AM; Borzanović MD; Krivokapić BM; Petrović IM; Djukanović BP
Acta Chir Iugosl; 2009; 56(1):47-52. PubMed ID: 19504989
[TBL] [Abstract][Full Text] [Related]
19. Failure of danaparoid anticoagulation for cardiopulmonary bypass.
Ariano RE; Bhattacharya SK; Moon M; Brownell LG
J Thorac Cardiovasc Surg; 2000 Jan; 119(1):167-8. PubMed ID: 10612777
[No Abstract] [Full Text] [Related]
20. [Anticoagulants in clinical practice].
Boneu B
Rev Prat; 1999 Oct; 49(15):1641-7. PubMed ID: 10581994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
